The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Clinical relevance of the ESKAPE pathogens
Abstract
In recent years, the Infectious Diseases Society of America has highlighted a faction of antibiotic-resistant bacteria (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.) - acronymically dubbed 'the ESKAPE pathogens' - capable of 'escaping' the biocidal action of antibiotics and mutually representing new paradigms in pathogenesis, transmission and resistance. This review aims to consolidate clinically relevant background information on the ESKAPE pathogens and provide a contemporary summary of bacterial resistance, alongside pertinent microbiological considerations necessary to face the mounting threat of antimicrobial resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
Bacterial biofilms: from the Natural environment to infectious diseases
Hall-Stoodley, L., Costerton, J. W., & Stoodley, P. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro821 · Cited by 7,143
Kaper, J. B., Nataro, J. P., & Mobley, H. L. T. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro818 · Cited by 5,583
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
Nikaido, H. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.593-656.2003 · Cited by 4,316
Determination of minimum inhibitory concentrations
Andrews, J. M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.suppl_1.5 · Cited by 4,129
J Antimicrob Chemother 1994; 33: 350–351
O'SHAUGHNESSY, E. M., & DAS, S. S. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.2.350 · Cited by 3,746
Dellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein, R. A., Burke, J. P., Huskins, W. C., Paterson, D. L., Fishman, N. O., Carpenter, C. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510393 · Cited by 3,362
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Wikler, M. A., & Clinical (2006) · Clinical and Laboratory Standards Institute eBooks · Cited by 2,843
Understanding biofilm resistance to antibacterial agents
Davies, D. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1008 · Cited by 2,781
Waves of resistance: Staphylococcus aureus in the antibiotic era
Chambers, H. F., & DeLeo, F. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2200 · Cited by 2,718
Podschun, R., & Ullmann, U. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.4.589 · Cited by 2,688
Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks
Kluytmans, J., van Belkum, A., & Verbrugh, H. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.3.505 · Cited by 2,595
Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,519
Allegranzi, B., Nejad, S. B., Combescure, C., Graafmans, W., Attar, H., Donaldson, L., & Pittet, D. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61458-4 · Cited by 2,514
How long do nosocomial pathogens persist on inanimate surfaces? A systematic review
Kramer, A., Schwebke, I., & Kampf, G. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-130 · Cited by 2,504
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Lina, G., Piemont, Y., Godail-Gamot, F., Bes, M., Peter, M.-O., Gauduchon, V., Vandenesch, F., & Etienne, J. (1999) · Clinical Infectious Diseases · doi:10.1086/313461 · Cited by 2,489
Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
Rice, L. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/533452 · Cited by 2,310
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,744
Vandenesch, F., Naimi, T., Enright, M. C., Lina, G., Nimmo, G. R., Heffernan, H., Liassine, N., Bes, M., Greenland, T., Reverdy, M.-E., et al. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0908.030089 · Cited by 1,727
Lung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
Bacterial Biofilms: An Emerging Link to Disease Pathogenesis
Parsek, M. R., & Singh, P. K. (2003) · Annual Review of Microbiology · doi:10.1146/annurev.micro.57.030502.090720 · Cited by 1,562
Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,540
Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?
Livermore, D. M. (2002) · Clinical Infectious Diseases · doi:10.1086/338782 · Cited by 1,453
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Li, J., Nation, R. L., Turnidge, J. D., Milne, R. W., Coulthard, K., Rayner, C. R., & Paterson, D. L. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70580-1 · Cited by 1,388
Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria
Piddock, L. J. V. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.382-402.2006 · Cited by 1,231
VANCOMYCIN-RESISTANT ENTEROCOCCI
Uttley, A. C., Collins, C. H., Naidoo, J., & George, R. C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91037-9 · Cited by 1,226
Linezolid resistance in a clinical isolate of Staphylococcus aureus
Tsiodras, S., Gold, H. S., Sakoulas, G., Eliopoulos, G. M., Wennersten, C., Venkataraman, L., Moellering, R. C., & Ferraro, M. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05410-1 · Cited by 1,033
Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
Strahilevitz, J., Jacoby, G. A., Hooper, D. C., & Robicsek, A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-09 · Cited by 928
Developing a new resource for drug discovery: marine actinomycete bacteria
Fenical, W., & Jensen, P. R. (2006) · Nature Chemical Biology · doi:10.1038/nchembio841 · Cited by 786
Liu, G. Y., Essex, A., Buchanan, J. T., Datta, V., Hoffman, H. M., Bastian, J. F., Fierer, J., & Nizet, V. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050846 · Cited by 752
Antibiotic resistance is prevalent in an isolated cave microbiome
Bhullar, K., Waglechner, N., Pawlowski, A., Koteva, K., Banks, E. D., Johnston, M. D., Barton, H. A., & Wright, G. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034953 · Cited by 736
Costerton, J. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(99)00018-7 · Cited by 727
Ruiz, J. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg222 · Cited by 711
Schwaber, M. J., & Carmeli, Y. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm318 · Cited by 626
Brent, L. (1983) · PubMed · Cited by 561
The Oxazolidinone Linezolid Inhibits Initiation of Protein Synthesis in Bacteria
Swaney, S. M., Aoki, H., Ganoza, M. C., & Shinabarger, D. L. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3251 · Cited by 555
Bacterial resistance to antibiotics: Active efflux and reduced uptake
KUMAR, A., & SCHWEIZER, H. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.004 · Cited by 529
Clauditz, A., Resch, A., Wieland, K.-P., Peschel, A., & Götz, F. (2006) · Infection and Immunity · doi:10.1128/iai.00204-06 · Cited by 509
Falagas, M. E., Kastoris, A. C., Kapaskelis, A. M., & Karageorgopoulos, D. E. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70325-1 · Cited by 487
The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
(2010) · Clinical Infectious Diseases · doi:10.1086/652237 · Cited by 484
Agricultural use of antibiotics and the evolution and transfer of antibiotic-resistant bacteria.
Khachatourians, G. G. (1998) · Europe PMC (PubMed Central) · Cited by 457
Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii
Vila, J., Martí, S., & Sánchez-Céspedes, J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl509 · Cited by 436
Wang, X., & Wood, T. K. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.05068-11 · Cited by 433
Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci
Bonten, M. J., Hayden, M. K., Nathan, C., van Voorhis, J., Matushek, M., Slaughter, S., Rice, T., & Weinstein, R. A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)02331-8 · Cited by 414
Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae
Bush, K. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.09.006 · Cited by 398
Modulation of virulence within a pathogenicity island in vancomycin-resistant Enterococcus faecalis
Shankar, N., Baghdayan, A. S., & Gilmore, M. S. (2002) · Nature · doi:10.1038/nature00802 · Cited by 393
Castanheira, M., Deshpande, L. M., Mathai, D., Bell, J. M., Jones, R. N., & Mendes, R. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01497-10 · Cited by 362
A scanning and transmission electron microscopic study of an infected endocardial pacemaker lead.
Marrie, T. J., Nelligan, J., & Costerton, J. W. (1982) · Circulation · doi:10.1161/01.cir.66.6.1339 · Cited by 347
Widmer, A. F., Frei, R., Rajacic, Z., & Zimmerli, W. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.1.96 · Cited by 315
Choi, C. H., Lee, E. Y., Lee, Y. C., Park, T. I., Kim, H. J., Hyun, S. H., Kim, S. A., Lee, S.-K., & Lee, J. C. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00538.x · Cited by 301
Linezolid resistance in clinical isolates of Staphylococcus aureus
Wilson, P. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg104 · Cited by 289
Microbial antagonism: a neglected avenue of natural products research
Burgess, J. G., Jordan, E. M., Bregu, M., Mearns-Spragg, A., & Boyd, K. G. (1999) · Journal of Biotechnology · doi:10.1016/s0168-1656(99)00054-1 · Cited by 280
Recover the lost art of drug discovery
Lewis, K. (2012) · Nature · doi:10.1038/485439a · Cited by 276
Antibiotics in the clinical pipeline in 2011
Butler, M. S., & Cooper, M. A. (2011) · The Journal of Antibiotics · doi:10.1038/ja.2011.44 · Cited by 272
Daptomycin‐Resistant, Methicillin‐Resistant Staphylococcus aureus Bacteremia
Mangili, A., Bica, I., Snydman, D. R., & Hamer, D. H. (2005) · Clinical Infectious Diseases · doi:10.1086/428616 · Cited by 256
Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA)
Appelbaum, P. C. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.07.011 · Cited by 248
Antitoxin MqsA helps mediate the bacterial general stress response
Wang, X., Kim, Y., Hong, S. H., Ma, Q., Brown, B. L., Pu, M., Tarone, A. M., Benedik, M. J., Peti, W., Page, R., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.560 · Cited by 244
Emergence of Metallo-β-Lactamase NDM-1-Producing Multidrug-Resistant Escherichia coli in Australia
Poirel, L., Lagrutta, E., Taylor, P., Pham, J., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00878-10 · Cited by 243
Development of Daptomycin Resistance In Vivo in Methicillin-Resistant Staphylococcus aureus
Hayden, M. K., Rezai, K., Hayes, R. A., Lolans, K., Quinn, J. P., & Weinstein, R. A. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5285-5287.2005 · Cited by 241
Stone, S. P., Fuller, C., Savage, J., Cookson, B., Hayward, A., Cooper, B., Duckworth, G., Michie, S., Murray, M., Jeanes, A., et al. (2012) · BMJ · doi:10.1136/bmj.e3005 · Cited by 229
Detection of NDM-1-Producing Klebsiella pneumoniae in Kenya
Poirel, L., Revathi, G., Bernabeu, S., & Nordmann, P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01247-10 · Cited by 202
Kochar, S., Sheard, T., Sharma, R., Hui, A., Tolentino, E., Allen, G., Landman, D., Bratu, S., Augenbraun, M., & Quale, J. (2009) · Infection Control & Hospital Epidemiology · doi:10.1086/596734 · Cited by 191
Complexity of the International Agro-Food Trade Network and Its Impact on Food Safety
Ercsey-Ravasz, M., Toroczkai, Z., Lakner, Z., & Baranyi, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037810 · Cited by 186
Virulence Factors of Enterococcus faecalis and Enterococcus faecium Blood Culture Isolates
Elsner, H.-A., Sobottka, I., Mack, D., Laufs, R., Claussen, M., & Wirth, R. (2000) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960050007 · Cited by 168
A review of tigecycline — the first glycylcycline
Peterson, L. R. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(09)70005-6 · Cited by 161
Brink, A. J., Coetzee, J., Clay, C. G., Sithole, S., Richards, G. A., Poirel, L., & Nordmann, P. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05956-11 · Cited by 121
Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06
Hope, R., Livermore, D. M., Brick, G., Lillie, M., Reynolds, R., & Surveillance, O. B. O. T. B. W. P. O. R. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn353 · Cited by 117
Synergy of different antibiotic combinations in biofilms of Staphylococcus epidermidis
Monzón, M., Oteiza, C., Leiva, J., & Amorena, B. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.6.793 · Cited by 114
Cathcart, G. R., Quinn, D. J., Greer, B., Harriott, P., Lynas, J. F., Gilmore, B., & Walker, B. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00776-10 · Cited by 113
Self-citationNon-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06
Livermore, D. M., Hope, R., Brick, G., Lillie, M., Reynolds, R., & Surveillance, O. B. O. T. B. W. P. O. R. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn351 · Cited by 102
Macrae, M. B., Shannon, K. P., Rayner, D., Kaiser, A. M., Hoffman, P. N., & French, G. L. (2001) · Journal of Hospital Infection · doi:10.1053/jhin.2001.1066 · Cited by 95
First Description of an Escherichia coli Strain Producing NDM-1 Carbapenemase in Spain
Solé, M., Pitart, C., Roca, I., Fàbrega, A., Salvador, P., Muñoz, L., Oliveira, I., Gascón, J., Marco, F., & Vilà, J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00642-11 · Cited by 93
Panton-Valentine Leukocidin and Staphyloccoccal Skin Infections in Schoolchildren1
Boubaker, K., Diebold, P., Blanc, D., Vandenesch, F., Praz, G., Dupuis, G., & Troillet, N. (2004) · Emerging infectious diseases · doi:10.3201/eid1001.030144 · Cited by 86
Adair, F. W., Geftic, S. G., & Gelzer, J. (1969) · Applied Microbiology · doi:10.1128/am.18.3.299-302.1969 · Cited by 83
Brown, D. F., Hope, R., Livermore, D. M., Brick, G., Broughton, K., George, R. C., Reynolds, R., & Surveillance, O. B. O. T. B. W. P. O. R. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn354 · Cited by 69
Livermore, D. M., Hope, R., Brick, G., Lillie, M., Reynolds, R., & Surveillance, O. B. O. T. B. W. P. O. R. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn352 · Cited by 64
Daptomycin: a novel lipopeptide antibiotic
Thorne, G. M., & Alder, J. D. (2002) · Clinical Microbiology Newsletter · doi:10.1016/s0196-4399(02)80007-1 · Cited by 62
Antiretroviral therapy of late presenters with advanced HIV disease
Battegay, M., Fehr, J. S., Flückiger, U. M., & Elzi, L. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn169 · Cited by 61
Moir, D. T., Opperman, T. J., Butler, M. M., & Bowlin, T. L. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.07.004 · Cited by 40
Cited by
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
Flores-Mireles, A. L., Walker, J. N., Caparon, M., & Hultgren, S. J. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3432 · Cited by 4,213
Implant infections: adhesion, biofilm formation and immune evasion
Arciola, C. R., Campoccia, D., & Montanaro, L. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0019-y · Cited by 2,241
Antibiotics and Bacterial Resistance in the 21st Century
Fair, R. J., & Tor, Y. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s14459 · Cited by 1,955
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., & Pardesi, K. R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00539 · Cited by 1,644
Schooley, R. T., Biswas, B., Gill, J. J., Hernandez-Morales, A., Lancaster, J., Lessor, L., Barr, J. J., Reed, S. L., Rohwer, F., Benler, S., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00954-17 · Cited by 1,254
Metadata
- Authors
- Pendleton, J. N., Gorman, S. P., & Gilmore, B. F.
- Venue
- Expert Review of Anti-infective Therapy
- Publisher
- Informa UK Limited
- Published
- 2013-03
- Volume
- 11
- Issue
- 3
- Pages
- 297-308
- ISSN
- 1478-7210 (ISSN-L)
- 1744-8336
- OpenAlex
- W2146157756
- Cited by
- 1,423
- References
- 83
- FWCI
- 21.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.